Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study

British Journal of Dermatology

Volumn 152, Issue 2, 2005, Pages 279-283

  Radakovic Fijan, S ^a   Blecha Thalhammer, U ^a   Schleyer, V ^b   Szeimies, R M ^b   Zwingers, T ^c   Honigsmann H ^a   Tanew, A ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Fa Estimate GmbH Augsburg   (Germany)

Author keywords

Aminolaevulinic acid; Photodynamic therapy; Psoriasis; Visible light

Indexed keywords

AMINOLEVULINIC ACID; KERATOLYTIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LIGHT IRRADIANCE; LOW DRUG DOSE; MALE; MEDICAL ASSESSMENT; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SKIN BURNING SENSATION; SKIN PIGMENTATION; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSORIASIS; RADIOTHERAPY DOSAGE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 14844326256     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06363.x     Document Type: Article

References (10)

1. Rapp SR, Feldmann SR, Exum ML et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41:401-7.
2. Boehncke WH, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light (letter). Lancet 1994; 343:801.
3. Collins P, Robinson DJ, Stringer MR et al. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137:743-9.
4. Robinson DJ, Collins P, Stringer MR et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 1999; 79:451-5.
5. Dawe RS, Cameron H, Yule S et al. UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 2002; 138:1071-6.
6. Stringer MR, Collins P, Robinson DJ et al. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolaevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 1996; 107:76-81.
7. Fritsch C, Lehmann P, Stahl W et al. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid. Br J Cancer 1999; 79:1603-8.
8. Bissonnette R, Zeng H, McLean DI et al. Psoriatic plaques exhibit red autofluorescence that is due to protoporphyrin IX. J Invest Dermatol 1998; 111:586-91.
9. Bissonnette R, Zeng H, McLean DI et al. Oral aminolevulinic acid induced protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells. Photochem Photobiol 2001; 74:339-45.
10. Boehncke WH, Elshorst-Schmidt T, Kaufmann R. Systemic photodynamic therapy is a safe and effective treatment for psoriasis (letter). Arch Dermatol 2000; 136:271-2.